Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zarate

Showing results (481-490 of 606) with videos related to

Pageof 61
Sort By:
The International Journal of Neuropsychopharmacology|September 13, 2011
Acute D-serine treatment produces antidepressant-like effects in rodentsOz Malkesman, Daniel R Austin, Tyson Tragon, et al.
Scientific Reports|August 1, 2023
Exome-wide association study of treatment-resistant depression suggests novel treatment targetsShrey B Shah, Teja N Peddada, Christopher Song, et al.
Journal of Affective Disorders|February 16, 2018
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scalesElizabeth D Ballard, Julia S Yarrington, Cristan A Farmer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Journal of Psychiatric Research|August 30, 2014
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxietyElizabeth D Ballard, Dawn F Ionescu, Jennifer L Vande Voort, et al.
Molecular Psychiatry|April 6, 2016
The role of adipokines in the rapid antidepressant effects of ketamineR Machado-Vieira, P W Gold, D A Luckenbaugh, et al.
The International Journal of Neuropsychopharmacology|November 2, 2011
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depressionGiacomo Salvadore, Jan Willem van der Veen, Yan Zhang, et al.
Bipolar Disorders|March 10, 2009
Hot and cold cognition in unmedicated depressed subjects with bipolar disorderJonathan P Roiser, Dara M Cannon, Shilpa K Gandhi, et al.
Pageof 61

Showing results (481-490 of 606) with videos related to

Sort By:
Pageof 61
The International Journal of Neuropsychopharmacology|September 13, 2011
Acute D-serine treatment produces antidepressant-like effects in rodentsOz Malkesman, Daniel R Austin, Tyson Tragon, et al.
Scientific Reports|August 1, 2023
Exome-wide association study of treatment-resistant depression suggests novel treatment targetsShrey B Shah, Teja N Peddada, Christopher Song, et al.
Journal of Affective Disorders|February 16, 2018
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scalesElizabeth D Ballard, Julia S Yarrington, Cristan A Farmer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Journal of Psychiatric Research|August 30, 2014
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxietyElizabeth D Ballard, Dawn F Ionescu, Jennifer L Vande Voort, et al.
Molecular Psychiatry|April 6, 2016
The role of adipokines in the rapid antidepressant effects of ketamineR Machado-Vieira, P W Gold, D A Luckenbaugh, et al.
The International Journal of Neuropsychopharmacology|November 2, 2011
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depressionGiacomo Salvadore, Jan Willem van der Veen, Yan Zhang, et al.
Bipolar Disorders|March 10, 2009
Hot and cold cognition in unmedicated depressed subjects with bipolar disorderJonathan P Roiser, Dara M Cannon, Shilpa K Gandhi, et al.
Pageof 61